MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis

Yiping Weng1,2, Weihao Duan2, Xuecheng Yu2

  • 1State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.

Cancer Science
|March 7, 2023
PubMed

Insights

MicroRNA-324-3p suppresses osteosarcoma progression by inhibiting the Warburg effect. This microRNA targets PGAM1, offering a potential therapeutic strategy for bone cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma (OS) is a primary bone cancer with limited treatment options.
  • MicroRNA (miR)-324-3p's role in OS progression and its mechanisms are largely unknown.
  • The Warburg effect, altered glucose metabolism, is implicated in cancer development.

Purpose of the Study:

  • To investigate the biological roles and mechanisms of miR-324-3p in osteosarcoma progression.
  • To explore the relationship between miR-324-3p, PGAM1, and the Warburg effect in OS.
  • To evaluate the therapeutic potential of targeting the miR-324-3p/PGAM1 axis.

Main Methods:

  • Assessed miR-324-3p expression in OS cell lines and tissues.
  • Overexpressed miR-324-3p to evaluate its functional impact on OS progression and the Warburg effect.
  • Identified PGAM1 as a direct target of miR-324-3p using 3'-UTR analysis.
  • Correlated PGAM1 expression with OS progression, aerobic glycolysis, and patient survival.

Main Results:

  • miR-324-3p expression was significantly reduced in OS.
  • Overexpression of miR-324-3p inhibited OS cell proliferation and migration, and reduced aerobic glycolysis.
  • miR-324-3p directly targeted and downregulated PGAM1 expression.
  • High PGAM1 expression promoted OS progression and aerobic glycolysis, correlating with poor patient survival.
  • PGAM1 overexpression partially rescued the tumor-suppressive effects of miR-324-3p.

Conclusions:

  • The miR-324-3p/PGAM1 axis is a critical regulator of osteosarcoma progression via modulation of the Warburg effect.
  • miR-324-3p acts as a tumor suppressor by inhibiting aerobic glycolysis in OS.
  • Targeting the miR-324-3p/PGAM1 pathway presents a promising molecular strategy for osteosarcoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K